type B that matches the circulating strains. The current vaccines may sometimes have the capacity to provide protection from matching viruses but have limitations that presents the need to manufacture ... phase two…
layer protein (SlpA). Using OVA as an antigen, we compared the gut mucosal adjuvant capacity of FliC to FLA-ST and to cholera toxin (CT). After immunizations in a mouse ... both a gut mucosal and systemic antibody…
unique way of integrating coastal development with conservation of the lagoon ecosystem. Recent research efforts have focused on Chikuâ??s carbon absorption capacities and the relationship between the aquaculture…
attempted to mimic the pathogens in their immune-enhancing capacity and thus to induce danger signals. This led to the development of life-saving vaccines based on live attenuated viruses
potential as a single administration vaccine with the capacity to rapidly provide broad protection against EboV and MarV. Profectus BioSciences has developed a replication competent attenuated rVSV vaccine delivery…
product on a global basis. Utilizing their substantial internal markets, growing manufacturing capacities and increased product development experience, regional vaccine manufacturers off er an �alternative� business…
hemorrhagic fever or shock syndrome or death. In response to these needs, we have developed a multivalent vaccine platform, based on the complex ad-vector vaccine platform (CAdVax), and have ... many advantages of the…
development of recombinant antibodies and vaccines has allowed us to treat and prevent a large number of life-threatening diseases. However, as things stand in 2013, the capacity and scalability ... pharmaceuticals…
spread of tuberculosis (TB) disease is urgent and not restricted to the developing world. Protective vaccination is the best and most cost-effective option to prevent the spread of infectious ... disease in human, it…
coli, S. cerevisiae, S. solfataricus and T. reesei . Microalgae research mainly focuses on development of microalgae species with high growth rate, high photosynthetic efficient, high-lipid/starch content ... native…
bacterium has an extraordinary ability to adapt to various environmental conditions and a notorious capacity to rapidly become resistant to virtually all antibiotics. However, the mechanisms to acquire the exogenous…
different types of adjuvants can polarize the cytokine response while inducing the same proliferative capacity, specificity and avidity of CD4 + T cells. Such responses were shown to be independent ... improve both…
enhance or modulate immune responses to a vaccine antigen, as measured by their capacity to induce strong primary immune responses, both cellular and humoral. More recently, the faculty of adjuvants ... survival…
subunit against N. meningitidis serogroup B. According to these properties of OMV, the adjuvants? capacity of OMVs has been well mentioned as well as other aspects of functional activity ... likely employed as a benefit…
more well-ordered trimers to limit routes of access to the CD4bs. We have developed new designs and methods to generate soluble, properly folded trimers that both present the conserved ... electron microscopic and…
show that a specific substitution inside this 3S motif permits the development of NAbs while preserving the capacity to block CD4 depletion. Methodology: To further characterize the 3S peptide
vast majority of pathogens invade through or cause disease at mucosal surfaces. Development of novel immunization strategies suitable for mucosal vaccines is widely desired to protect against infectious diseases…
peptides from Plasmodium spp. Bearing in mind that such targeted-molecules shown low immunogenic capacity when tested as vaccine components, these have to be rationally modified to overcome such ... clues for including…
Vaccine Network - Africa (MVN-A) was established to improve immunization program capacity in sub-Saharan Africa. Collaborative partnerships developed and implemented effective Expanded Program on Immunization (EPI)…
threats, production of conventional egg-based vaccines is time consuming and of limited capacity. We have developed a novel DNA vaccine where viral hemagglutinin (HA) is bivalently targeted to Major
production of conventional egg-based vaccines is time consuming and of limited capacity. We have now developed a novel DNA vaccine where viral hemagglutinin (HA) is bivalently targeted to Major
adjuvants have been used with unclear or negative results. The development of therapeutic vaccines against CHB requires proofing the capacity of the formulation to subvert a tolerated immune response. NASVAC ... phase…
vivo transduction is an effective means to deliver immunogens or therapeutic antibody. We have developed genetic Ad delivery vectors which promote prolonged, high-level secretions of VNAs or immunogens ... which has an…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.